ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1
- 1 January 2000
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 57 (1) , 274-281
- https://doi.org/10.1046/j.1523-1755.2000.00818.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- In Chronic Nephropathies Prolonged ACE Inhibition Can Induce RemissionJournal of the American Society of Nephrology, 1999
- Pathophysiology of Progressive NephropathiesNew England Journal of Medicine, 1998
- Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trialThe Lancet, 1998
- Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathiesKidney International, 1998
- Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathyThe Lancet, 1997
- Genetics of the renin-angiotensin system and renal diseaseCurrent Opinion in Nephrology and Hypertension, 1997
- The role of angiotensin I-converting enzyme gene polymorphism in renal diseaseCurrent Opinion in Nephrology and Hypertension, 1996
- Polymorphisms of the renin-angiotensin system genes in progressive renal diseasesKidney International, 1996
- Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal InsufficiencyNew England Journal of Medicine, 1996
- The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic NephropathyNew England Journal of Medicine, 1993